Eastman Chemical (EMN)
(Delayed Data from NYSE)
$100.29 USD
-2.08 (-2.03%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $99.11 -1.18 (-1.18%) 5:20 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.29 USD
-2.08 (-2.03%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $99.11 -1.18 (-1.18%) 5:20 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Zacks News
Eastman Chemical (EMN) Gains on Cost Cuts and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) benefits from cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
LyondellBasell (LYB) Reports Next Week: What to Expect
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Eastman Chemical (EMN) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Eastman Chemical (EMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Eastman Chemical (EMN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Eastman Chemical (EMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman Chemical (EMN) Shares Pop 17% in 3 Months: Here's Why
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-management actions and innovation and maintains a disciplined approach to capital allocation.
Should Value Investors Buy Eastman Chemical (EMN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include GigaCloud Technology, SkyWest, Ramaco Resources, Eastman Chemical and Catalyst Pharmaceuticals
by Zacks Equity Research
GigaCloud Technology, SkyWest, Ramaco Resources, Eastman Chemical and Catalyst Pharmaceuticals are part of the Screen of the Week article.
5 Value Stocks With Strong Earnings Yield to Rev Up Returns
by Rimmi Singhi
Consider investing in high-yield value stocks like GCT, SKYW, METC, EMN and CPRX to unlock your portfolio's potential.
Is Arkema (ARKAY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Buy Eastman Chemical (EMN) Stock Right Now
by Zacks Equity Research
Eastman Chemical (EMN) benefits from cost-management actions, operational execution and innovation.
Eastman's (EMN) Naia Gets Global Recycled Standard Certification
by Zacks Equity Research
The GRS certification received by Eastman (EMN) is owned by Textile Exchange, a global non-profit dedicated to long-term transformation in the fashion and textile industries.
Eastman Chemical (EMN) Shares Up 13% in 3 Months: Here's Why
by Zacks Equity Research
Eastman Chemical (EMN) benefits from cost-management actions and innovation and maintains a disciplined approach to capital allocation.
Eastman Chemical (EMN) Raises Dividend for 14th Straight Year
by Zacks Equity Research
Eastman's (EMN) latest dividend hike reflects the board's confidence in its ability to deliver solid earnings and maintain its track record of strong cash flow generation.
Why You Should Retain Eastman Chemical (EMN) in Your Portfolio
by Zacks Equity Research
While Eastman Chemical (EMN) faces headwinds from weak demand and inventory de-stocking, it benefits from productivity actions and innovation.
Eastman Chemical (EMN) Wraps Up Sale of Texas City Operations
by Zacks Equity Research
The proceeds of the divestiture are expected to be used for debt repayment of Eastman (EMN) in the near future.
Eastman (EMN) Announces Strategic Alliance With Ostium Group
by Zacks Equity Research
Eastar 6763 Renew is powered by Eastman's (EMN) innovative molecular recycling technology.
Eastman Chemical (EMN) Q3 Earnings & Sales Beat Estimates
by Zacks Equity Research
Revenues of Eastman Chemical (EMN) decline in Q3 primarily due to lower sales volume and reduced selling prices.
Eastman Chemical (EMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Eastman Chemical (EMN) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Eastman Chemical (EMN) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 1.38% and 0.28%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical (EMN) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Eastman (EMN) is expected to have benefited from cost-cutting and productivity initiatives, as well as its innovation-driven growth strategy amid demand weakness in Q3.
Albemarle (ALB) Completes MARBL Joint Venture Restructuring
by Zacks Equity Research
Albemarle (ALB) completes MARBL JV restructuring and takes full ownership of Kemerton facility.
Eastman Chemical (EMN) Benefits From Cost Cuts and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
DuPont (DD) Unveils Low-Cyclics Silicone Soft Skin Adhesive
by Zacks Equity Research
The adhesive is created as part of DuPont's (DD) efforts to broaden its portfolio of solutions to support the expanding medical device market.
Analysts Estimate Eastman Chemical (EMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman (EMN) Exploring Expansion of Interlayers in Europe
by Zacks Equity Research
Eastman (EMN) is evaluating ways to expand its asset footprint to maintain high quality, dependability and services for its automotive and architectural customers.